Yuko Kanbayashi, Takeshi Ishikawa, Eigo Otsuji, Koichi Takayama. Predictors for the development of thromboembolic events in cancer patients treated with bevacizumab, ramucirumab, and aflibercept: a single-institution retrospective analysis. Oncology. 2024
Yuko Kanbayashi, Asuka Kojima, Haruka Wakabayashi, Tadashi Shimizu, Mayako Uchida. Evaluation of time to onset and outcome of cardiac adverse events associated with nilotinib using post-marketing surveillance. Oncology. 2023
Yuko Kanbayashi, Momoko Kobayashi, Miku Anzai, Tadashi Shimizu, Mayako Uchida. Evaluation of time to onset and outcome of lung adverse events related to pembrolizumab using marketing surveillance. Oncology. 2023
Yuko Kanbayashi, Tadashi Shimizu, Asuka Kojima, Miku Anzai, Rika Kawai, Mayako Uchida. Evaluation of lung adverse events with nivolumab using the spontaneous reporting system in Japan. Scientific reports. 2023. 13. 1. 8819-8819
In Focus on Chemotherapy-induced Peripheral Neuropathies and Post-Herpetic Neuralgia: Horizons in Cancer Research.
Nova Science Publishers, (New York) 2015
Substance Abuse: In Prevalence, Genetic and Environmental Risk Factors and Prevention
Nova Science Publishers, (New York) 2014
In Peripheral Neuropathy - A New Insight into the Mechanism, Evaluation and Management of a Complex Disorder
InTech - Open Access Publisher, (Rijeka, Croatia) 2013
In Peripheral Neuropathy - Advances in Diagnostic and Therapeutic, edited by Ghazala Hayat
InTech - Open Access Publisher, (Rijeka, Croatia) 2012
Methotrexate: In Pharmacology, Clinical Uses and Adverse Effects,
Nova Science Publishers, (New York) 2011 ISBN:9781621005964